Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gordon

Showing results (1211-1220 of 1,291) with videos related to

Pageof 130
Sort By:
Vaccine|April 3, 2024
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisationG Tembo, M Mayuni, R Kamng'ona, et al.
Journal of the American Academy of Dermatology|November 6, 2007
From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasisMark Lebwohl, Jerry Bagel, Joel M Gelfand, et al.
NPJ Vaccines|February 26, 2026
Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UKEvaristar Kudowa, Godwin Tembo, Anthony E Chirwa, et al.
Annals of the American Thoracic Society|February 27, 2025
The Epidemiology and Impact of Hypoxemia in Sub-Saharan Africa: Prevalence, Practices, and OutcomesInnocent Sulani, Lauren A Onofrey, Letizia Trevisi, et al.
BMC Medicine|March 29, 2022
AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2Marah G Chibwana, Thandeka Moyo-Gwete, Gaurav Kwatra, et al.
Global Heart|July 21, 2019
The Malawi NCD BRITE Consortium: Building Research Capacity, Implementation, and Translation Expertise for Noncommunicable DiseasesJoep J van Oosterhout, Mina Hosseinipour, Adamson S Muula, et al.
Thorax|September 10, 2025
Acute breathlessness as a cause of hospitalisation in Malawi: a prospective, patient-centred study to evaluate causes and outcomesStephen A Spencer, Florence Malowa, David McCarty, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
In depth analysis of patients with severe SARS-CoV-2 in sub-Saharan Africa demonstrates distinct clinical and immunological profilesB Morton, K G Barnes, C Anscombe, et al.
Journal of Autism and Developmental Disorders|January 19, 2000
The screening and diagnosis of autistic spectrum disordersP A Filipek, P J Accardo, G T Baranek, et al.
The New England Journal of Medicine|June 15, 2016
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque PsoriasisKenneth B Gordon, Andrew Blauvelt, Kim A Papp, et al.
Pageof 130

Showing results (1211-1220 of 1,291) with videos related to

Sort By:
Pageof 130
Vaccine|April 3, 2024
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisationG Tembo, M Mayuni, R Kamng'ona, et al.
Journal of the American Academy of Dermatology|November 6, 2007
From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasisMark Lebwohl, Jerry Bagel, Joel M Gelfand, et al.
NPJ Vaccines|February 26, 2026
Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UKEvaristar Kudowa, Godwin Tembo, Anthony E Chirwa, et al.
Annals of the American Thoracic Society|February 27, 2025
The Epidemiology and Impact of Hypoxemia in Sub-Saharan Africa: Prevalence, Practices, and OutcomesInnocent Sulani, Lauren A Onofrey, Letizia Trevisi, et al.
BMC Medicine|March 29, 2022
AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2Marah G Chibwana, Thandeka Moyo-Gwete, Gaurav Kwatra, et al.
Global Heart|July 21, 2019
The Malawi NCD BRITE Consortium: Building Research Capacity, Implementation, and Translation Expertise for Noncommunicable DiseasesJoep J van Oosterhout, Mina Hosseinipour, Adamson S Muula, et al.
Thorax|September 10, 2025
Acute breathlessness as a cause of hospitalisation in Malawi: a prospective, patient-centred study to evaluate causes and outcomesStephen A Spencer, Florence Malowa, David McCarty, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
In depth analysis of patients with severe SARS-CoV-2 in sub-Saharan Africa demonstrates distinct clinical and immunological profilesB Morton, K G Barnes, C Anscombe, et al.
Journal of Autism and Developmental Disorders|January 19, 2000
The screening and diagnosis of autistic spectrum disordersP A Filipek, P J Accardo, G T Baranek, et al.
The New England Journal of Medicine|June 15, 2016
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque PsoriasisKenneth B Gordon, Andrew Blauvelt, Kim A Papp, et al.
Pageof 130